基于生物信息学和机器学习算法的非酒精性脂肪性肝炎细胞衰老关键基因的分析与验证
Analysis and Validation of Key Cellular Senescence Genes in Non-Alcoholic Steatohepatitis Based on Bioinformatics and Machine Learning Algorithm
摘要: 目的:非酒精性脂肪性肝炎(Non-alcoholic Steatohepatitis, NASH)是发病机制涉及多重病理生理过程,其中细胞衰老对NASH的发生发展起着关键作用。基于此,针对细胞衰老相关基因及其调控网络的深入研究,可能为NASH的靶向治疗提供新的干预策略。方法:从GEO数据库获取NASH相关转录组测序数据集GSE89632和GSE37031。采用WGCNA筛选出与NASH高度相关的基因模块,对其进行富集分析,以阐明其潜在生物学功能。将差异表达基因(Differentially expressed genes, DEGs)与CellAge数据库中的细胞衰老基因集取交集,筛选出细胞衰老DEGs。对细胞衰老DEGs进行功能富集分析,系统揭示其在NASH中的分子调控网络。随后,整合机器学习算法筛选Hub基因。最后,构建ROC曲线并计算AUC评估Hub基因的诊断效能。结果:WGCNA分析表明,共有10个基因模块被识别,其中黑色模块基因与NASH呈现最显著相关。富集分析显示,关键模块的基因与细胞衰老和免疫炎症密切相关。对训练基因集进行差异分析,共获得细胞衰老相关DEGs共51个。进一步GO和KEGG分析显示,细胞衰老DEGs主要与衰老和免疫炎症相关。对细胞衰老DEGs进行三种机器学习算法,综合对比后,FOS、MYC和PIM1被确定为关键基因。通过绘制ROC曲线检验在训练集和测试集中的诊断效能。关键基因的ROC曲线下面积均大于0.7且这三个基因较对照组均显著低表达。结论:本研究通过整合生物信息学分析和机器学习算法,最终鉴定出FOS、MYC和PIM1三个关键调控基因,均在NASH患者中显著低表达,且与免疫炎症反应密切相关。
Abstract: Objective: Non-alcoholic steatohepatitis (NASH) is a pathogenesis involving multiple pathophysiological processes, in which cellular senescence plays a key role in the development of NASH. Based on this, in-depth studies of cellular senescence-related genes and their regulatory networks may provide new intervention strategies for targeted therapy of NASH. Methods: NASH-related transcriptome sequencing datasets GSE89632 and GSE37031 were obtained from the GEO database, and WGCNA was used to screen out the gene modules that were highly related to NASH, and they were enriched and analyzed to elucidate their potential biological functions. Differentially expressed genes (DEGs) were intersected with the cellular senescence gene sets in the CellAge database to screen the cellular senescence DEGs. Functional enrichment analysis was performed on the cellular senescence DEGs to systematically reveal their molecular regulatory networks in NASH. Subsequently, machine learning algorithms were integrated to screen Hub genes. Finally, ROC curves were constructed and AUC was calculated to evaluate the diagnostic efficacy of Hub genes. Results: WGCNA analysis showed that a total of 10 gene modules were identified, with the black module genes showing the most significant association with NASH. Enrichment analysis showed that the key module genes were closely associated with cellular senescence and immune inflammation. Differential analysis of the training gene set yielded a total of 51 cellular senescence-related DEGs. Further GO and KEGG analysis showed that cellular senescence DEGs were mainly associated with senescence and immune inflammation. Three machine learning algorithms were performed on the cellular senescence DEGs, and FOS, MYC and PIM1 were identified as key genes after comprehensive comparison. Diagnostic efficacy in the training and test sets was examined by plotting ROC curves. The area under the ROC curve for the key genes was greater than 0.7 and all three genes were significantly under expressed compared to the control. Conclusion: By integrating bioinformatics analysis and machine learning algorithms, the present study finally identified three key regulatory genes, FOS, MYC and PIM1, which were significantly under expressed in NASH patients and closely associated with immune-inflammatory responses.
文章引用:朱月, 毋中明. 基于生物信息学和机器学习算法的非酒精性脂肪性肝炎细胞衰老关键基因的分析与验证[J]. 临床个性化医学, 2025, 4(3): 540-552. https://doi.org/10.12677/jcpm.2025.43379

参考文献

[1] Wang, T., Wang, R., Bu, Z., Targher, G., Byrne, C.D., Sun, D., et al. (2022) Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Kidney Disease. Nature Reviews Nephrology, 18, 259-268. [Google Scholar] [CrossRef] [PubMed]
[2] Younossi, Z.M., Golabi, P., Paik, J.M., Henry, A., Van Dongen, C. and Henry, L. (2023) The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology, 77, 1335-1347. [Google Scholar] [CrossRef] [PubMed]
[3] Deprince, A., Haas, J.T. and Staels, B. (2020) Dysregulated Lipid Metabolism Links NAFLD to Cardiovascular Disease. Molecular Metabolism, 42, Article ID: 101092.
[4] Younossi, Z., Anstee, Q.M., Marietti, M., et al. (2018) Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 15, 11-20.
[5] 姜珊. 基于转录组和代谢组探讨非酒精性脂肪肝炎动态发病机制及转化熊胆粉干预机制研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2024.
[6] Zeng, J., Fan, J. and Francque, S.M. (2024) Therapeutic Management of Metabolic Dysfunction Associated Steatotic Liver Disease. United European Gastroenterology Journal, 12, 177-186. [Google Scholar] [CrossRef] [PubMed]
[7] Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., et al. (2009) A Crucial Role for Adipose Tissue P53 in the Regulation of Insulin Resistance. Nature Medicine, 15, 1082-1087. [Google Scholar] [CrossRef] [PubMed]
[8] Aravinthan, A., Scarpini, C., Tachtatzis, P., Verma, S., Penrhyn-Lowe, S., Harvey, R., et al. (2013) Hepatocyte Senescence Predicts Progression in Non-Alcohol-Related Fatty Liver Disease. Journal of Hepatology, 58, 549-556. [Google Scholar] [CrossRef] [PubMed]
[9] Bonnet, L., Alexandersson, I., Baboota, R.K., Kroon, T., Oscarsson, J., Smith, U., et al. (2022) Cellular Senescence in Hepatocytes Contributes to Metabolic Disturbances in Nash. Frontiers in Endocrinology, 13, Article ID: 957616. [Google Scholar] [CrossRef] [PubMed]
[10] Gorgoulis, V., Adams, P.D., Alimonti, A., Bennett, D.C., Bischof, O., Bishop, C., et al. (2019) Cellular Senescence: Defining a Path Forward. Cell, 179, 813-827. [Google Scholar] [CrossRef] [PubMed]
[11] Takasugi, M., Yoshida, Y. and Ohtani, N. (2022) Cellular Senescence and the Tumour Microenvironment. Molecular Oncology, 16, 3333-3351. [Google Scholar] [CrossRef] [PubMed]
[12] Yao, J., Li, Y. and Wang, H. (2023) The Roles of Myeloid Cells in Aging-Related Liver Diseases. International Journal of Biological Sciences, 19, 1564-1578.
[13] 陈铭. 大数据时代的整合生物信息学[J]. 生物信息学, 2022, 20(2): 75-83.
[14] Xue, G., Hua, L., Zhou, N., et al. (2021) Characteristics of Immune Cell Infiltration and Associated Diagnostic Biomarkers in Ulcerative Colitis: Results from Bioinformatics Analysis. Bioengineered, 12, 252-265.
[15] Yang, Y., Cao, Y., Han, X., Ma, X., Li, R., Wang, R., et al. (2023) Revealing EXPH5 as a Potential Diagnostic Gene Biomarker of the Late Stage of COPD Based on Machine Learning Analysis. Computers in Biology and Medicine, 154, Article ID: 106621. [Google Scholar] [CrossRef] [PubMed]
[16] 王建茹, 李彬, 彭广操, 等. 基于加权基因共表达网络分析挖掘ECMO治疗后心源性休克结局的核心枢纽基因[J]. 临床心血管病杂志, 2021, 37(5): 433-440.
[17] Meng, Q., Li, X. and Xiong, X. (2022) Identification of Hub Genes Associated with Non-Alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis. Frontiers in Genetics, 13, Article ID: 872518. [Google Scholar] [CrossRef] [PubMed]
[18] The Gene Ontology Consortium, Aleksander, S.A., Balhoff, J., et al. (2023) The Gene Ontology Knowledgebase in 2023. Genetics, 224, iyad031.
[19] Kanehisa, M. (2002) The KEGG Database. Novartis Foundation Symposium, Vol. 247, 91-101.
[20] Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., et al. (2015) Robust Enumeration of Cell Subsets from Tissue Expression Profiles. Nature Methods, 12, 453-457. [Google Scholar] [CrossRef] [PubMed]
[21] Hardy, T., Oakley, F., Anstee, Q.M., et al. (2016) Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annual Review of Pathology, 11, 451-496.
[22] Vilar-Gomez, E., Vuppalanchi, R., Mladenovic, A., et al. (2023) Prevalence of High-Risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results from NHANES 2017-2018. Clinical Gastroenterology and Hepatology, 21, 115-124e7.
[23] 马美娜, 刘巾玮. 治疗伴有肝纤维化的非酒精性脂肪性肝炎新药Resmetirom的临床评价[J]. 中国处方药, 2025, 23(1): 107-110.
[24] Loft, A., Alfaro, A.J., Schmidt, S.F., Pedersen, F.B., Terkelsen, M.K., Puglia, M., et al. (2021) Liver-Fibrosis-Activated Transcriptional Networks Govern Hepatocyte Reprogramming and Intra-Hepatic Communication. Cell Metabolism, 33, 1685-1700.e9. [Google Scholar] [CrossRef] [PubMed]
[25] Xiao, Y., Batmanov, K., Hu, W., Zhu, K., Tom, A.Y., Guan, D., et al. (2023) Hepatocytes Demarcated by EphB2 Contribute to the Progression of Nonalcoholic Steatohepatitis. Science Translational Medicine, 15, eadc9653. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, X., Zhou, D., Strakovsky, R., et al. (2012) Hepatic Cellular Senescence Pathway Genes Are Induced through Histone Modifications in a Diet-Induced Obese Rat Model. American Journal of Physiology Gastrointestinal and Liver Physiology, 302, G558-G564.
[27] Laish, I., Mannasse-Green, B., Hadary, R., et al. (2016) Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis. Cytogenetic and Genome Research, 150, 93-99.
[28] Campisi, J. and d’Adda di Fagagna, F. (2007) Cellular Senescence: When Bad Things Happen to Good Cells. Nature Reviews Molecular Cell Biology, 8, 729-740. [Google Scholar] [CrossRef] [PubMed]
[29] Mills, K.H.G. (2022) IL-17 and Il-17-Producing Cells in Protection versus Pathology. Nature Reviews Immunology, 23, 38-54. [Google Scholar] [CrossRef] [PubMed]
[30] Van Loo, G. and Bertrand, M.J.M. (2023) Death by TNF: A Road to Inflammation. Nature Reviews Immunology, 23, 289-303.
[31] Vallejo, A., Valencia, K. and Vicent, S. (2017) All for One and FOSL1 for All: FOSL1 at the Crossroads of Lung and Pancreatic Cancer Driven by Mutant KRAS. Molecular & Cellular Oncology, 4, e1314239.
[32] Jiang, X., Xie, H., Dou, Y., Yuan, J., Zeng, D. and Xiao, S. (2019) Expression and Function of FRA1 Protein in Tumors. Molecular Biology Reports, 47, 737-752. [Google Scholar] [CrossRef] [PubMed]
[33] Tulchinsky, E. (2000) Fos Family Members: Regulation, Structure and Role in Oncogenic Transformation. Histology and Histopathology, 15, 921-928.
[34] Dorn, C., Engelmann, J.C., Saugspier, M., Koch, A., Hartmann, A., Müller, M., et al. (2014) Increased Expression of C-Jun in Nonalcoholic Fatty Liver Disease. Laboratory Investigation, 94, 394-408. [Google Scholar] [CrossRef] [PubMed]
[35] Videla, L.A., Tapia, G., Rodrigo, R., et al. (2009) Liver NF-kappaB and AP-1 DNA Binding in Obese Patients. Obesity (Silver Spring), 17, 973-979.
[36] Yang, D., Xiao, C., Long, F., et al. (2019) Fra-1 Plays a Critical Role in Angiotensin II-Induced Vascular Senescence. The FASEB Journal, 33, 7603-7614.
[37] Koh, C.M., Bezzi, M., Low, D.H.P., Ang, W.X., Teo, S.X., Gay, F.P.H., et al. (2015) MYC Regulates the Core Pre-mRNA Splicing Machinery as an Essential Step in Lymphomagenesis. Nature, 523, 96-100. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, H., Lu, J., Stevens, T., Roberts, A., Mandel, J., Avula, R., et al. (2023) Premature Aging and Reduced Cancer Incidence Associated with Near-Complete Body-Wide Myc Inactivation. Cell Reports, 42, Article ID: 112830. [Google Scholar] [CrossRef] [PubMed]
[39] Schuster, S., Cabrera, D., Arrese, M. and Feldstein, A.E. (2018) Triggering and Resolution of Inflammation in NASH. Nature Reviews Gastroenterology & Hepatology, 15, 349-364. [Google Scholar] [CrossRef] [PubMed]
[40] Kazankov, K., Jørgensen, S.M.D., Thomsen, K.L., Møller, H.J., Vilstrup, H., George, J., et al. (2018) The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Nature Reviews Gastroenterology & Hepatology, 16, 145-159. [Google Scholar] [CrossRef] [PubMed]
[41] Rensen, S.S., Slaats, Y., Nijhuis, J., Jans, A., Bieghs, V., Driessen, A., et al. (2009) Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis. The American Journal of Pathology, 175, 1473-1482. [Google Scholar] [CrossRef] [PubMed]
[42] Wolf, M.J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., et al. (2014) Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes. Cancer Cell, 26, 549-564. [Google Scholar] [CrossRef] [PubMed]